Aducanumab: First Approval
Year: 2021
Type: article
Source: Drugs
Author: Sohita Dhillon
Institution: Springer Nature (New Zealand)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3185184038
